Biogen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	3,863	2,375	1,050	3,419	2,261	1,331
Short-Term Investments	97.6	-	-	1,474	1,541	1,279
Cash & Short-Term Investments	3,960	2,375	1,050	4,893	3,803	2,610
Cash Growth	133.07%	126.21%	-78.54%	28.67%	45.68%	-41.69%
Accounts Receivable	1,850	1,869	2,100	2,136	1,962	2,327
Other Receivables	-	-	430	798.8	-	-
Receivables	1,850	1,869	2,530	2,935	1,962	2,327
Inventory	2,209	2,461	2,527	1,344	1,352	1,069
Other Current Assets	916.8	752.5	752	618.8	740.8	881.1
Total Current Assets	8,937	7,457	6,859	9,791	7,857	6,887
Property, Plant & Equipment	3,406	3,538	3,730	3,703	3,792	3,845
Long-Term Investments	485.6	423.8	625.8	1,776	2,826	3,671
Goodwill	6,491	6,479	6,219	5,749	5,761	5,762
Other Intangible Assets	9,332	9,691	8,363	1,850	2,221	3,084
Long-Term Deferred Tax Assets	312.4	324.2	928.6	1,226	1,415	1,370
Other Long-Term Assets	214.1	136.7	119.2	459.3	5.5	-
Total Assets	29,208	28,049	26,845	24,554	23,877	24,619
Accounts Payable	413.1	424.2	403.3	491.5	589.2	454.9
Accrued Expenses	1,693	1,504	1,453	1,497	1,382	1,633
Current Portion of Long-Term Debt	-	1,749	150	-	999.1	-
Current Portion of Leases	-	86.4	90.3	97.2	89.1	83.2
Current Income Taxes Payable	103.3	548.3	257.4	259.9	174.7	142
Other Current Liabilities	1,080	1,218	1,080	927.6	1,064	1,429
Total Current Liabilities	3,290	5,529	3,434	3,273	4,298	3,742
Long-Term Debt	6,285	4,547	6,788	6,281	6,274	7,426
Long-Term Leases	305	334.5	400	333	330.4	402
Long-Term Deferred Tax Liabilities	358.1	190.5	641.8	334.7	694.5	1,033
Other Long-Term Liabilities	761.8	732.3	781.1	944.2	1,321	1,330
Total Liabilities	11,000	11,333	12,045	11,166	12,918	13,933
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1
Additional Paid-In Capital	797.7	569.4	302.5	73.3	68.2	-
Retained Earnings	20,602	19,260	17,628	16,467	13,912	13,976
Treasury Stock	-2,977	-2,977	-2,977	-2,977	-2,977	-2,977
Comprehensive Income & Other	-214.8	-136.2	-153.7	-164.9	-106.7	-299
Total Common Equity	18,208	16,716	14,799	13,398	10,896	10,700
Minority Interest	-	-	-	-9.5	63.5	-14.2
Shareholders' Equity	18,208	16,716	14,799	13,388	10,960	10,686
Total Liabilities & Equity	29,208	28,049	26,845	24,554	23,877	24,619
Total Debt	6,590	6,717	7,429	6,711	7,693	7,911
Net Cash (Debt)	-2,630	-4,342	-6,379	-1,113	-2,998	-4,529
Net Cash Per Share	-17.95	-29.76	-43.81	-7.62	-20.04	-28.08
Filing Date Shares Outstanding	146.7	146.37	145.36	144.49	146.96	152.34
Total Common Shares Outstanding	146.7	145.8	144.9	144.1	147	152.4
Working Capital	5,647	1,928	3,425	6,518	3,558	3,145
Book Value Per Share	124.11	114.65	102.14	92.98	74.12	70.21
Tangible Book Value	2,385	545.9	217.2	5,799	2,914	1,854
Tangible Book Value Per Share	16.26	3.74	1.50	40.24	19.82	12.16
Land	-	202.4	202.4	202.4	207.5	119.8
Buildings	-	1,964	1,601	1,593	1,700	1,025
Machinery	-	2,169	1,765	1,673	1,653	1,090
Construction In Progress	-	308.4	975.4	888.8	770.3	1,951
Leasehold Improvements	-	137.8	135.7	107.7	121	104.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.